Skip to main content


Are you looking for a more high throughput screening assay to risk assess chemicals, compounds, novel drugs and biologics?

Are you seeking an autologus human skin equivalent model? 

Are you looking for a speedier timeline to hazard identification?


Skimune®3D – a novel testing platform

Alcyomics have developed an in vitro 3D autologous skin equivalent model as a testing platform which is representative of normal human skin tissue. Skimune®3D is a full-thickness 3D human skin equivalent model containing dermal fibroblasts and epidermal keratinocytes from the same healthy donor tissue providing an autologous system for the safety testing of drugs, chemicals and cosmetics as an alternative to animal models. We have also developed this model to identify toxicological endpoints such as dose toxicity, cell viability, apoptosis and necrosis and the effects of test compounds or drugs on cytokines, growth factors and chemokine levels.

Skimune®3D is made using ReproCELL Europe’s highly porous  polystyrene scaffold for 3D cell culture (Alvetex®). Cells grown in Alvetex® possess a natural tissue-like structure allowing them to behave more physiologically relevant. Cells are able to maintain their in vivo morphology, behaviour and responsiveness within the Skimune®3D in vitro system.

More information on the benefits of Alvetex® can be found here

Figure 1: Skimune®3D is an in vitro model representative of normal human skin tissue.

Histopathological comparison of normal skin with the full-thickness 3D autologous human skin equivalent model (A.) and immunofluorescence for involucrin, loricrin and keratin XIV (protein markers of epidermal differentiation) and collagen III (B.). These results demonstrate that Skimune®3D is representative of normal human tissue.


Key Benefits

  • Solves the problem of the ban on animal testing for cosmeceuticals – 7th Amendment to the Cosmetics Directive (EU Directive 76/768/EEC2), March 2009/2013.
  • Reduces development costs
  • Increases product safety profile
  • Reduces the use of animal testing
  • Speedier timeline to hazard identification

For more information on the Skimune®3D platform and how it can help your business please contact us



  • This form collects your name and email so what we can add your to our newsletter list and send you relevant updates via email. Read our privacy policy for details on how we manage your data.